Regulation of Virus-Specific T cell Responses by TNF
Regulation of Virus-Specific T cell Responses by TNF
批准号:
7877040
负责人:
Michael Allen Brehm
金额:
$20.56万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-06-19 至 2011-05-31
关键词:
Allergic ReactionAntigensAntiviral ResponseAutoimmune DiseasesB-LymphocytesBeliefCD4 Positive T LymphocytesCD8B1 geneCell physiologyCellular ImmunityComplexDataDefectDevelopmentDrug FormulationsEffector CellEventFrequenciesGenerationsGoalsHomeostasisHourImmune responseImmune systemImmunityIn VitroInfectionInfection ControlInflammationInflammatoryKnockout MiceLeadMediatingMemoryPathway interactionsPeptide/MHC ComplexPhasePhenotypeProcessProductionRegulationResearchRoleSignal TransductionStagingT cell responseT-Cell ActivationT-LymphocyteTNF geneTestingTimeTransplanted tissueVaccinationVaccinesViralVirusWild Type Mousebasecytokineimmunopathologyin vivonovelpathogenprogramspublic health relevanceresponsetumor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): T cells are involved in many beneficial aspects of the immune system including the control of infections, tumor surveillance, generation of B cell responses, and regulation of homeostasis. In some instances, activated T cells are also detrimental to a host, mediating autoimmune disease, allergic reactions, immunopathology, and the rejection of transplanted tissues. The activation of naive T cells is a tightly controlled process, involving a complex network of signaling events that is still not completely understood. The early stages of T cell activation are critical to the programming of differentiation pathways for T cells, and this process is extremely sensitive to levels of inflammation. We have shown that naive phenotype T cells rapidly produce TNF within 5 hours of TCR engagement. This result was unexpected because naive T cells are thought to acquire effector functions only after undergoing a differentiation process and suggests that naive T cells produce this inflammatory cytokine during the innate phase of the immune response. Our recent data indicate that T cell-produced TNF has a suppressive effect on the generation of anti-viral responses, as TNF-deficient virus-specific T cells are present at significantly higher frequencies after infection as compared to wild type T cells. These findings reveal a novel self-regulatory function for antigen-specific T cells that is mediated by the production of TNF. The long-term goals for this proposed research plan are to further characterize the role of T cell-produced TNF in the generation of T cell responses and to determine if antagonizing TNF-activity at early times after infection will enhance immune responses. The specific hypothesis to be tested is that T cell- produced TNF has important regulatory functions for the development of functional cellular immunity. We propose to evaluate the importance of T cell-produced TNF by the following specific aims: SPECIFIC AIM#1: To determine the mechanisms by which T cell-produced TNF regulates the generation of virus-specific T cell responses. SPECIFIC AIM#2: To determine if a transient blockade of TNF-signaling will enhance the generation of virus-specific T cell responses after infection and vaccination. PUBLIC HEALTH RELEVANCE: The proposed research initiative will advance our basic understanding of how the immune system responds to infectious pathogens. The results of these studies may lead to the development of more effective vaccines that generate stronger anti-viral immunity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Immunogenicity of Human Stem Cell-Derived Beta Cells and Muscle Cells in Humanized Mice
-
批准号:10218287
-
项目类别:
-
资助金额:$82.38万
-
财政年份:2019
-
负责人:Michael Allen Brehm
-
依托单位:
Humanized mice for investigating human stem cell-derived microglia in Alzheimers Disease
-
批准号:10120199
-
项目类别:
-
资助金额:$42.08万
-
财政年份:2019
-
负责人:Michael Allen Brehm
-
依托单位:
Immunogenicity of Human Stem Cell-Derived Beta Cells and Muscle Cells in Humanized Mice
-
批准号:10449121
-
项目类别:
-
资助金额:$82.38万
-
财政年份:2019
-
负责人:Michael Allen Brehm
-
依托单位:
Live imaging of SARS-CoV-2 infection in novel humanized mice
-
批准号:10400392
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2019
-
负责人:Michael Allen Brehm
-
依托单位:
Novel humanized mouse model developed from cord blood CD34 positive HSC and autologous iPS cell derived thymus
-
批准号:9915858
-
项目类别:
-
资助金额:$78.27万
-
财政年份:2017
-
负责人:Michael Allen Brehm
-
依托单位:
Novel humanized mouse model developed from cord blood CD34 positive HSC and autologous iPS cell derived thymus
-
批准号:9368151
-
项目类别:
-
资助金额:$79.96万
-
财政年份:2017
-
负责人:Michael Allen Brehm
-
依托单位:
Novel humanized mouse model developed from cord blood CD34 positive HSC and autologous iPS cell derived thymus
-
批准号:10153677
-
项目类别:
-
资助金额:$78.27万
-
财政年份:2017
-
负责人:Michael Allen Brehm
-
依托单位:
Development and Validation of Novel NSG Mouse Models for Human Stem Cell Therapy
-
批准号:8666892
-
项目类别:
-
资助金额:$78.04万
-
财政年份:2014
-
负责人:Michael Allen Brehm
-
依托单位:
Humanized Mouse Avatars for T1D
-
批准号:10170353
-
项目类别:
-
资助金额:$100.88万
-
财政年份:2014
-
负责人:Michael Allen Brehm
-
依托单位:
Retrogenic humanized mice for the study of T1D
-
批准号:8728475
-
项目类别:
-
资助金额:$27.14万
-
财政年份:2014
-
负责人:Michael Allen Brehm
-
依托单位:
Humanized Mouse Avatars for T1D
-
批准号:10020970
-
项目类别:
-
资助金额:$101.15万
-
财政年份:2014
-
负责人:Michael Allen Brehm
-
依托单位:
Humanized Mouse Avatars for T1D
-
批准号:8813948
-
项目类别:
-
资助金额:$411.0万
-
财政年份:2014
-
负责人:Michael Allen Brehm
-
依托单位:
Development and Validation of Novel NSG Mouse Models for Human Stem Cell Therapy
-
批准号:8849519
-
项目类别:
-
资助金额:$74.88万
-
财政年份:2014
-
负责人:Michael Allen Brehm
-
依托单位:
Humanized Mouse Avatars for T1D
-
批准号:10801488
-
项目类别:
-
资助金额:$42.5万
-
财政年份:2014
-
负责人:Michael Allen Brehm
-
依托单位:
Development and Validation of Novel NSG Mouse Models for Human Stem Cell Therapy
-
批准号:9018073
-
项目类别:
-
资助金额:$76.41万
-
财政年份:2014
-
负责人:Michael Allen Brehm
-
依托单位:
Development and Validation of Novel NSG Mouse Models for Human Stem Cell Therapy
-
批准号:9233212
-
项目类别:
-
资助金额:$72.59万
-
财政年份:2014
-
负责人:Michael Allen Brehm
-
依托单位:
Humanized Mouse Avatars for T1D
-
批准号:10412982
-
项目类别:
-
资助金额:$100.6万
-
财政年份:2014
-
负责人:Michael Allen Brehm
-
依托单位:
Virology and Technology Core
-
批准号:8279395
-
项目类别:
-
资助金额:$18.13万
-
财政年份:2011
-
负责人:Michael Allen Brehm
-
依托单位:
Virology and Technology Core
-
批准号:7994928
-
项目类别:
-
资助金额:$18.34万
-
财政年份:2010
-
负责人:Michael Allen Brehm
-
依托单位:
Regulation of Virus-Specific T cell Responses by TNF
-
批准号:7708481
-
项目类别:
-
资助金额:$24.59万
-
财政年份:2009
-
负责人:Michael Allen Brehm
-
依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
-
批准号:2022J011295
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:王亚伟
-
依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
-
批准号:30801055
-
项目类别:青年科学基金项目
-
资助金额:19.0万元
-
批准年份:2008
-
负责人:王丽梅
-
依托单位: